Loading provider…
Loading provider…
Hematology & Oncology Physician in Jacksonville, FL
NPI: 1306171871Primary Practice Location
MAYO CLINIC
4500 San Pablo Rd S, Jacksonville, FL
Primary Employer
Mayo Clinic Jacksonville
mayoclinic.org
HQ Phone
Get MD Taimur's Phone NumberMobile
Get MD Taimur's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2011 - 2026
GA State Medical License
2014 - 2026
NY State Medical License
2010 - 2011

American Board of Internal Medicine
Hematology
University at Buffalo
Fellowship • Hematology and Medical Oncology
2009 - 2010
Fellowship • Hematology and Medical Oncology
2007 - 2009
Mount Sinai Medical Center of Florida
Residency • Internal Medicine
2004 - 2007
King Edward Medical University
Medical School
Until 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96413Infusion of chemotherapy into a vein up to 1 hour | 199 | 225 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 136 | 192 |
| 3 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 127 | 295 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 123 | 156 |
| 5 | J2405Injection, ondansetron hydrochloride, per 1 mg | 95 | 1,048 |
Authors: Nicole Lamanna, Javier Pinilla-Ibarz, Rami Manochakian, Sikander Ailawadhi, Asher Chanan-Khan
Journal: Blood Adv
Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis.
Authors: Dan Lebovic, Rachid Baz, Kelvin Lee, Mohamad Hussein, Mehul Patel, Asher Chanan-Khan
Journal: Leuk Lymphoma
Authors: R Wright
Journal: Mayo Clin Proc
Lead Sponsor: Mayo Clinic
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Dexamethasone, DRUG: Ibrutinib, DRUG: Bortezomib
Lead Sponsor: Prothena Biosciences Ltd.
Intervention / Treatment: DRUG: Placebo, DRUG: NEOD001
Lead Sponsor: OrphAI Therapeutics
Intervention / Treatment: DRUG: Rituximab, DRUG: Atezolizumab, DRUG: LAM-002A